INSECTICID2024-04-012024-06-30 INSECTICID2024-04-012024-06-30in-bse-fin:OneOperatingExpenses01Member INSECTICID2024-06-30 INSECTICID2024-04-012024-06-30in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss01Member INSECTICID2024-04-012024-06-30in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss02Member INSECTICID2024-04-012024-06-30in-bse-fin:OneItemsThatWillNotBeReclassifiedToProfitAndLoss03Member iso4217:INRxbrli:purexbrli:sharesiso4217:INRxbrli:shares 532851 INSECTICID NA Insecticides (India) Limited Equity 2024-04-01 2025-03-31 2024-08-09 2024-07-22 INR Lakhs First quarter 13:30:00 15:00:00 2024-08-09 2024-08-09 Not applicable Single segment Agro-chemicals 2024-04-01 2024-06-30 Unaudited Standalone 6566853000.00 25388000.00 6592241000.00 3391244000.00 209813000.00 1159126000.00 386318000.00 16247000.00 71301000.00 702058000.00 5936107000.00 656134000.00 0.00 656134000.00 172139000.00 -7364000.00 164775000.00 0.00 491359000.00 0.00 0.00 0.00 0.00 491359000.00 -16843000.00 474516000.00 0.00 0.00 295978000.00 10 16.60 16.60 0.00 0.00 16.60 16.60 1) The above Unaudited Standalone Financial Results have been published in accordance with Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended. The results have been reviewed and recommended by the Audit Committee and approved by the Board of Directors at their meeting held on August 09, 2024. The Statutory Auditors have carried out a limited review of financial results. The Limited Review Report and Quarterly Financial Results are available on the Stock Exchange website at www.bseindia.com, www.nseindia.com and on the Company's website www.insecticidesindia.com. 2) The above Standalone financial results have been prepared in accordance with the Indian Accounting Standard (Ind AS), the provisions of the Companies Act, 2013 ( the Act ), as applicable and guidelines issued by the Securities and Exchange Board of India ( SEBI ). The Ind AS are prescribed under Section 133 of the Act read with Rule 3 of the Companies (Indian Accounting Standards) Rules, 2015 and subsequent amendments thereto. 3) The Company's wholly owned subsidiary IIL Biologicals Limited has successfully completed the rights issue of Equity Shares of INR 200.00 Lakhs on June 28, 2024. 4) The figures of the quarter ended March 31, 2024 are the balancing figures between the audited figures in respect of the full financial year and the unaudited published year-to-date figures for nine months ended December 31, 2023, respectively. Other Expenses 702058000.00 Changes in fair value of FVTOCI equity instruments -21837000.00 Remeasurement of net defined benefit plans -125000.00 Income tax relating to these items 5119000.00 -16843000.00 0.00 0.00